Robert A. Wolff

Oncology

210 Ashville Ave # 408
Cary, NC 27518

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 228 publications

Overall survival of immunotherapy versus standard of care in chemorefractory microsatellite stable metastatic colorectal cancer: a propensity score matched analysis of 708 patients.

Overall survival of immunotherapy versus standard of care in chemorefractory microsatellite stable metastatic colorectal cancer: a propensity score matched analysis of 708 patients.

Journal: Journal for immunotherapy of cancer

Published: August 10, 2026

Patterns of progression and survival in patients with mismatch repair deficient/ microsatellite instability- high metastatic colorectal cancer treated with immunotherapy.

Patterns of progression and survival in patients with mismatch repair deficient/ microsatellite instability- high metastatic colorectal cancer treated with immunotherapy.

Journal: The oncologist

Published: March 02, 2026

Clinical and translational results from a phase 1 trial of gemcitabine/nab-paclitaxel with nivolumab/ipilimumab or hydroxychloroquine/ipilimumab in untreated metastatic pancreatic adenocarcinoma.

Clinical and translational results from a phase 1 trial of gemcitabine/nab-paclitaxel with nivolumab/ipilimumab or hydroxychloroquine/ipilimumab in untreated metastatic pancreatic adenocarcinoma.

Journal: Journal for immunotherapy of cancer

Published: January 12, 2026

A retrospective analysis of taxane-based chemotherapy in small bowel adenocarcinoma.

A retrospective analysis of taxane-based chemotherapy in small bowel adenocarcinoma.

Journal: The oncologist

Published: September 29, 2025

Clinicopathologic Characteristics of Brain Metastasis of Pancreatic Ductal Adenocarcinoma.

Clinicopathologic Characteristics of Brain Metastasis of Pancreatic Ductal Adenocarcinoma.

Journal: The American journal of surgical pathology

Published: September 12, 2025

Phase I trial of binimetinib plus hydroxychloroquine in patients with previously treated metastatic pancreatic cancer.

Phase I trial of binimetinib plus hydroxychloroquine in patients with previously treated metastatic pancreatic cancer.

Journal: The oncologist

Published: July 24, 2025

A spatial atlas of chemoradiation therapy in pancreatic cancer identifies cellular and microenvironmental determinants of persister populations.

A spatial atlas of chemoradiation therapy in pancreatic cancer identifies cellular and microenvironmental determinants of persister populations.

Journal: bioRxiv : the preprint server for biology

Published: July 16, 2025

Pegfilgrastim (Neulasta)-induced acute aortitis: a case report.

Pegfilgrastim (Neulasta)-induced acute aortitis: a case report.

Journal: European heart journal. Case reports

Published: July 07, 2025

Long-chain sulfatide enrichment is an actionable metabolic vulnerability in intraductal papillary mucinous neoplasm (IPMN)-associated pancreatic cancers.

Long-chain sulfatide enrichment is an actionable metabolic vulnerability in intraductal papillary mucinous neoplasm (IPMN)-associated pancreatic cancers.

Journal: Gut

Published: March 04, 2025

KRAS mutation detection by liquid biopsy for pancreatic ductal adenocarcinoma.

KRAS mutation detection by liquid biopsy for pancreatic ductal adenocarcinoma.

Journal: Journal of hematology & oncology

Published: February 19, 2025

Clinicopathologic Features Associated with Survival for Immune Checkpoint Blockade in Patients with Metastatic Anal Cancer.

Clinicopathologic Features Associated with Survival for Immune Checkpoint Blockade in Patients with Metastatic Anal Cancer.

Journal: Cancers

Published: January 09, 2025

Mutational and co-mutational landscape of early onset colorectal cancer.

Mutational and co-mutational landscape of early onset colorectal cancer.

Journal: Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals

Published: January 06, 2025

Showing 1-12 of 228

Last Updated: 09/26/2026